Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice

This publication has 61 references indexed in Scilit:

• The VesiVax system: a method for rapid vaccine development
  Frontiers in Bioscience-Landmark, 2008
• Dose and timing requirements for immunogenicity of viral poultry vaccine antigen: investigations of emulsion-based depot function
  Avian Pathology, 2007
• Memory CD8 T-Cell Differentiation during Viral Infection
  Journal of Virology, 2004
• Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10ΔPK
  Vaccine, 2002
• Seroprevalence of Herpes Simplex Virus Type 2 Infection Among Attendees of a Sexually Transmitted Disease Clinic in Italy
  Sexually Transmitted Diseases, 2000
• Immunological requirements for a subunit vaccine against tuberculosis
  Immunology & Cell Biology, 1997
• The Regulation of Immunity to Leishmania Major
  Annual Review of Immunology, 1995
• Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
  Immunology Today, 1993
• Virus Neutralizing Activity Induced by Synthetic Peptides of Glycoprotein D of Herpes Simplex Virus Type 1, selected by their Reactivity with Hyperimmune Sera from Mice
  Journal of General Virology, 1990
• A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.
  The Journal of Experimental Medicine, 1987